E-LIB Suche - Ergebnisse für: Putnam, Wendy S.

1

Efficacy, safety, and tolerability of lebrikizumab in adole..:

Szefler, Stanley J. ; Roberts, Graham ; Rubin, Adalberto S....
Clinical and Translational Allergy. 12 (2022) 7 - p. , 2022

Link: https://doi.org/10.1002/..

2

Population Pharmacokinetics and Exposure‐Response Relations..:

Kotani, Naoki ; Dolton, Michael ; Svensson, Robin J....
The Journal of Clinical Pharmacology. 62 (2022) 7 - p. 905-917 , 2022

Link: https://doi.org/10.1002/..

3

Translational and pharmacokinetic‐pharmacodynamic applicati..:

Chan, Phyllis ; Ding, Han Ting ; Liederer, Bianca M....
Clinical and Translational Science. 14 (2021) 5 - p. 1945-1954 , 2021

Link: https://doi.org/10.1111/..

4

Pharmacokinetics and exposure-efficacy relationships of oma..:

Zhu, Rui ; Owen, Ryan ; Wilkins, Justin...
Pulmonary Pharmacology & Therapeutics. 71 (2021) - p. 102080 , 2021

Link: https://doi.org/10.1016/..

5

Comparability Considerations and Challenges for Expedited D..:

Schrieber, Sarah J. ; Putnam, Wendy S. ; Chow, Edwin Chiu Yuen...
Drugs in R&D. 20 (2020) 4 - p. 301-306 , 2020

Link: https://doi.org/10.1007/..

6

A randomized, placebo‐controlled trial evaluating effects o..:

Austin, Cary D. ; Gonzalez Edick, Melissa ; Ferrando, Ronald E....
Clinical & Experimental Allergy. 50 (2020) 12 - p. 1342-1351 , 2020

Link: https://doi.org/10.1111/..

7

Monoclonal Antibodies: From Structure to Therapeutic Applic..:

, In: Pharmaceutical Biotechnology,

Deng, Rong ; Boswell, C. Andrew ; Putnam, Wendy S.... - p. 151-190 , 2019

Link: https://doi.org/10.1007/..

8

Efficacy and safety of lebrikizumab in adult patients with ..:

Korenblat, Philip ; Kerwin, Edwin ; Leshchenko, Igor...
Respiratory Medicine. 134 (2018) - p. 143-149 , 2018

Link: https://doi.org/10.1016/..

9

A Pharmacokinetic Bioequivalence Study Comparing Pirfenidon..:

Pan, Lin ; Belloni, Paula ; Ding, Han Ting...
Advances in Therapy. 34 (2017) 9 - p. 2071-2082 , 2017

Link: https://doi.org/10.1007/..

10

Model-based clinical pharmacology profiling and exposure-re..:

Zhu, Rui ; Zheng, Yanan ; Dirks, Nathanael L....
Pulmonary Pharmacology & Therapeutics. 46 (2017) - p. 88-98 , 2017

Link: https://doi.org/10.1016/..

11

Population-Based Efficacy Modeling of Omalizumab in Patient..:

Zhu, Rui ; Zheng, Yanan ; Putnam, Wendy S....
The AAPS Journal. 15 (2013) 2 - p. 559-570 , 2013

Link: https://doi.org/10.1208/..

12

Dose-ranging study of lebrikizumab in asthmatic patients no..:

Noonan, Michael ; Korenblat, Phillip ; Mosesova, Sofia...
Journal of Allergy and Clinical Immunology. 132 (2013) 3 - p. 567-574.e12 , 2013

Link: https://doi.org/10.1016/..

13

Pharmacokinetic, pharmacodynamic and immunogenicity compara..:

Putnam, Wendy S. ; Prabhu, Saileta ; Zheng, Yanan..
Trends in Biotechnology. 28 (2010) 10 - p. 509-516 , 2010

Link: https://doi.org/10.1016/..

14

Use of Quantitative Pharmacology in the Development of HAE1..:

Putnam, Wendy S. ; Li, Jing ; Haggstrom, Jonas...
The AAPS Journal. 10 (2008) 2 - p. , 2008

Link: https://doi.org/10.1208/..

15

Effect of the MDR1 C3435T Variant and P‐Glycoprotein Induct..:

Putnam, Wendy S. ; Woo, Jonathan M. ; Huang, Yong.
The Journal of Clinical Pharmacology. 45 (2005) 4 - p. 411-421 , 2005

Link: https://doi.org/10.1177/..